Provided are conjugates between (a) an antibody or antigen-binding fragment thereof that binds to p97 (melanotransferrin MTf) and (b) an agent of interest, and related compositions and methods, for example, to improve pharmacokinetics and/or delivery of the agent of interest across the blood-brain barrier (BBB) and into tissues of the central nervous system (CNS).